Skip to main content

December 2025

Interview for MPharm, MSc in QA, QC, Production at AMI Drugs

Skilled in Batch Records, SOPs, BMR, and validation documentation. Proficient in calibration, routine equipment checks, and troubleshooting.
Johnson & Johnson Looking for Medical Science Liaison
Good understanding of medical affairs function. Understanding of local regulatory policy and industrys code of practice related to drug registration, pharmaceutical promotion and clinical research.
PLI Scheme drives manufacturing of 36 Medical Devices in India
Total 36 different medical devices are manufactured under Production Linked Incentive (PLI) Scheme for promoting domestic manufacturing of medical devices in India. These medical devices belong to different portfolios such as Imaging & Diagnostics, Critical Care & Emergency, Interventional CardioVascular, Renal Care Devices, Orthopaedic Implants, Oncology and specialist divisions.
Target set to increase the number of Jan Aushadhi Kendras to 25,000 by March 2027.
Target set to increase the number of Jan Aushadhi Kendras to 25,000 by March 2027.
New antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission

Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission.

Clues to Alzheimer’s disease may be hiding in our ‘junk’ DNA
When most of us think of DNA, we have a vague idea it’s made up of genes that give us our physical features, our behavioural quirks, and keep our cells and organs running.
Keytruda with Padcev improves survival of cisplatin-eligible patients with MIBC
KEYNOTE-B15, also known as EV-304, is an open-label, randomized Phase 3 trial evaluating perioperative KEYTRUDA in combination with Padcev and surgery (radical cystectomy and pelvic lymph node dissection) versus neoadjuvant chemotherapy and surgery in patients with MIBC who are cisplatin-eligible.
FDA approves RYBREVANT FASPRO™ : A first-of-its-kind subcutaneous therapy for EGFR-Mutated Lung Cancer
The U.S. Food and Drug Administration (FDA) has granted approval to RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), marking a significant advancement in the treatment of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer
Openings for D.Pharm, B.Pharm at Municipal Corporation Health Department, 07 posts
D.Pharm, Registration with MSPC / PCI Council is mandatory, preference will be given to candidates with experience.
Hiring Pharmacist in Government Medical College Hospital
Pharmacist with Diploma in Integrated Pharmacy with Computer Knowledge including MS Office, MS word, MS Power Point and MS Excel, MS access would be essential.